athenahealth, Inc. (ATHN) Director Sells $106,376.00 in Stock

athenahealth, Inc. (NASDAQ:ATHN) Director Brandon H. Hull sold 800 shares of the firm’s stock in a transaction dated Friday, December 1st. The shares were sold at an average price of $132.97, for a total transaction of $106,376.00. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link.

Brandon H. Hull also recently made the following trade(s):

  • On Monday, November 20th, Brandon H. Hull sold 800 shares of athenahealth stock. The shares were sold at an average price of $130.00, for a total transaction of $104,000.00.
  • On Friday, October 20th, Brandon H. Hull sold 800 shares of athenahealth stock. The shares were sold at an average price of $130.00, for a total transaction of $104,000.00.

athenahealth, Inc. (NASDAQ ATHN) traded up $1.85 during trading on Monday, hitting $134.51. 809,564 shares of the company’s stock traded hands, compared to its average volume of 578,104. athenahealth, Inc. has a one year low of $90.11 and a one year high of $158.66. The firm has a market cap of $5,308.75, a PE ratio of 112.42, a P/E/G ratio of 4.98 and a beta of 1.57. The company has a debt-to-equity ratio of 0.35, a current ratio of 1.67 and a quick ratio of 1.67.

athenahealth (NASDAQ:ATHN) last released its earnings results on Thursday, October 19th. The health services provider reported $0.56 earnings per share (EPS) for the quarter, topping the Thomson Reuters’ consensus estimate of $0.50 by $0.06. athenahealth had a net margin of 2.65% and a return on equity of 6.78%. The business had revenue of $304.60 million for the quarter, compared to analysts’ expectations of $310.52 million. During the same period last year, the company earned $0.60 earnings per share. The company’s quarterly revenue was up 10.1% on a year-over-year basis. equities research analysts predict that athenahealth, Inc. will post 1.2 earnings per share for the current fiscal year.

Several institutional investors and hedge funds have recently added to or reduced their stakes in the stock. Advisor Group Inc. boosted its position in shares of athenahealth by 2.8% in the second quarter. Advisor Group Inc. now owns 1,744 shares of the health services provider’s stock worth $244,000 after acquiring an additional 47 shares during the last quarter. Teacher Retirement System of Texas boosted its position in shares of athenahealth by 2.2% in the second quarter. Teacher Retirement System of Texas now owns 3,156 shares of the health services provider’s stock worth $444,000 after acquiring an additional 67 shares during the last quarter. Seven Bridges Advisors LLC boosted its position in shares of athenahealth by 5.4% in the second quarter. Seven Bridges Advisors LLC now owns 1,303 shares of the health services provider’s stock worth $183,000 after acquiring an additional 67 shares during the last quarter. State of Wisconsin Investment Board boosted its position in shares of athenahealth by 0.9% in the second quarter. State of Wisconsin Investment Board now owns 7,868 shares of the health services provider’s stock worth $1,106,000 after acquiring an additional 70 shares during the last quarter. Finally, The Manufacturers Life Insurance Company boosted its position in shares of athenahealth by 7.7% in the second quarter. The Manufacturers Life Insurance Company now owns 1,179 shares of the health services provider’s stock worth $166,000 after acquiring an additional 84 shares during the last quarter.

ATHN has been the subject of several recent research reports. Cantor Fitzgerald restated a “hold” rating and set a $120.00 target price on shares of athenahealth in a report on Friday, October 27th. Robert W. Baird restated a “buy” rating and set a $170.00 target price on shares of athenahealth in a report on Thursday, August 31st. KeyCorp restated a “buy” rating and set a $170.00 target price on shares of athenahealth in a report on Sunday, September 17th. Leerink Swann dropped their target price on shares of athenahealth from $155.00 to $125.00 and set a “market perform” rating for the company in a report on Monday, October 23rd. Finally, BidaskClub upgraded shares of athenahealth from a “strong sell” rating to a “sell” rating in a report on Saturday. Two analysts have rated the stock with a sell rating, fourteen have issued a hold rating and eleven have issued a buy rating to the company’s stock. The stock currently has a consensus rating of “Hold” and a consensus target price of $143.22.

COPYRIGHT VIOLATION WARNING: “athenahealth, Inc. (ATHN) Director Sells $106,376.00 in Stock” was first published by Chaffey Breeze and is owned by of Chaffey Breeze. If you are accessing this article on another publication, it was copied illegally and republished in violation of international trademark and copyright law. The original version of this article can be read at https://www.chaffeybreeze.com/2017/12/04/athenahealth-inc-athn-director-sells-106376-00-in-stock.html.

athenahealth Company Profile

athenahealth, Inc provides network-based medical record, revenue cycle, patient engagement, care coordination and population health services. The Company also offers Epocrates and other point-of-care mobile applications. The Company delivers majority of its service offerings through a single instance of cloud-based software, athenaNet.

Insider Buying and Selling by Quarter for athenahealth (NASDAQ:ATHN)

Receive News & Ratings for athenahealth Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for athenahealth Inc. and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply